Juan Liu
Research Subjects
Juan Liu has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
Aihua Peng
State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Keyuan Road 4, Gaopeng Street, Chengdu 610041, China
1 shared publication- Caifeng Xie
School of Basic Medical Sciences, Nanchang University, Nanchang, China
1 shared publication - Haiyan Zhao
Department of Clinical Laboratory Medicine The People Hospital of Qingyang City Qingyang China
1 shared publication - Heying Pei
Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University
1 shared publication - Hongjun Zheng
Department of Clinical Laboratory Medicine The People Hospital of Qingyang City Qingyang China
1 shared publication Huijun Lai
State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Keyuan Road 4, Gaopeng Street, Chengdu 610041, China
1 shared publication
Latest Publications
- Open Access
- 29 January 2020
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 34 (2) , e23199
High prevalence of breastmilk‐acquired cytomegalovirus infection in jaundiced infants
Background: Our objective was to evaluate the prevalence and different diagnostic methods of breastmilk (BM)‐acquired cytomegalovirus (CMV) infection in a pathologically jaundiced cohort. Methods: A total of 400 infants confirmed with pathological jaundice at The People's Hospital of Qingyang City were screened for BM‐acquired CMV infection between February 2018 and February 2019. A total of 300 infants were finally enrolled in our study. CMV infection was confirmed by detecting both CMV‐DNA in various samples using FQ‐PCR and CMV‐IgM with chemiluminescence. Clinical and other laboratory data were collected from these infants during their hospitalization or regular visits. Results: Ninety‐eight (32.67%) subjects were confirmed to be BM CMV‐DNA–positive, and 18 (18.37%) were diagnosed with a BM‐acquired CMV infection. All 18 (100%) infants with a BM‐acquired CMV infection were CMV‐DNA–positive in urine, while 5 (27.78%) cases and 11 (61.11%) cases were confirmed in plasma and peripheral blood mononuclear cells (PBMCs), respectively. Only 6 (33.33%) infants were CMV‐IgM–positive. Birthweight, direct bilirubin, aspartate aminotransferase, and the viral load in BM of the BM‐acquired CMV group were higher than those in the non‐infected group ( P < .05). Low birthweight and viral load in BM were risk factors for BM‐acquired CMV infection. Detecting CMV‐DNA in urine samples exhibited better performance than the other methods for screening BM‐acquired CMV infections. Conclusions: Our study found a high prevalence of BM‐acquired CMV infection in jaundiced infants, and detecting CMV‐DNA in a urine sample was the most sensitive method for disease screening.
- 29 January 2020
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 34 (2) , e23199
Open AccessHigh prevalence of breastmilk‐acquired cytomegalovirus infection in jaundiced infants
Background: Our objective was to evaluate the prevalence and different diagnostic methods of breastmilk (BM)‐acquired cytomegalovirus (CMV) infection in a pathologically jaundiced cohort. Methods: A total of 400 infants confirmed with pathological jaundice at The People's Hospital of Qingyang City were screened for BM‐acquired CMV infection between February 2018 and February 2019. A total of 300 infants were finally enrolled in our study. CMV infection was confirmed by detecting both CMV‐DNA in various samples using FQ‐PCR and CMV‐IgM with chemiluminescence. Clinical and other laboratory data were collected from these infants during their hospitalization or regular visits. Results: Ninety‐eight (32.67%) subjects were confirmed to be BM CMV‐DNA–positive, and 18 (18.37%) were diagnosed with a BM‐acquired CMV infection. All 18 (100%) infants with a BM‐acquired CMV infection were CMV‐DNA–positive in urine, while 5 (27.78%) cases and 11 (61.11%) cases were confirmed in plasma and peripheral blood mononuclear cells (PBMCs), respectively. Only 6 (33.33%) infants were CMV‐IgM–positive. Birthweight, direct bilirubin, aspartate aminotransferase, and the viral load in BM of the BM‐acquired CMV group were higher than those in the non‐infected group ( P < .05). Low birthweight and viral load in BM were risk factors for BM‐acquired CMV infection. Detecting CMV‐DNA in urine samples exhibited better performance than the other methods for screening BM‐acquired CMV infections. Conclusions: Our study found a high prevalence of BM‐acquired CMV infection in jaundiced infants, and detecting CMV‐DNA in a urine sample was the most sensitive method for disease screening.
- 25 May 2016
- Published by Taylor & Francis in Synthesis and Reactivity in Inorganic, Metal-Organic, and Nano-Metal Chemistry
- Vol. 46 (12) , 1871-1878
Synthesis, Characterization, X-Ray Crystal Structures, and Catalytic Epoxidation Activity of cis-Dioxomolybdenum(VI) and Oxovanadium(V) Complexes With N'-(2-Hydroxy-4-methoxybenzylidene)-4-trifluoromethylbenzohydrazide
A new cis-dioxomolybdenum(VI) complex, [MoO2LMeOH] (1) and a new oxovanadium(V) complex, [VOL(OMe)MeOH] (2), with potentially tridentate ONO aroylhydrazone Schiff base derived from 4-methoxysalicylaldehyde with 4-trifluoromethylbenzohydrazide, have been synthesized and fully characterized on the basis of elemental analysis, FT-IR, molar conductivity, and electronic spectra. Structures of the complexes have been accomplished by single-crystal X-ray diffraction. The complexes have distorted octahedral structures in which the aroylhydrazones behave as binegative ligands. It is also revealed from the crystal structures that the Mo(VI) and V(V) centers adopt NO5 donor environment, and the octahedral coordination is furnished by oxido groups and oxygen atoms of methanol or deprotonated methanol molecules. The catalytic properties were investigated for epoxidation of cyclooctene using aqueous tert-butyl hydroperoxide as the oxidant.
- 25 May 2016
- Published by Taylor & Francis in Synthesis and Reactivity in Inorganic, Metal-Organic, and Nano-Metal Chemistry
- Vol. 46 (12) , 1871-1878
Synthesis, Characterization, X-Ray Crystal Structures, and Catalytic Epoxidation Activity of cis-Dioxomolybdenum(VI) and Oxovanadium(V) Complexes With N'-(2-Hydroxy-4-methoxybenzylidene)-4-trifluoromethylbenzohydrazide
A new cis-dioxomolybdenum(VI) complex, [MoO2LMeOH] (1) and a new oxovanadium(V) complex, [VOL(OMe)MeOH] (2), with potentially tridentate ONO aroylhydrazone Schiff base derived from 4-methoxysalicylaldehyde with 4-trifluoromethylbenzohydrazide, have been synthesized and fully characterized on the basis of elemental analysis, FT-IR, molar conductivity, and electronic spectra. Structures of the complexes have been accomplished by single-crystal X-ray diffraction. The complexes have distorted octahedral structures in which the aroylhydrazones behave as binegative ligands. It is also revealed from the crystal structures that the Mo(VI) and V(V) centers adopt NO5 donor environment, and the octahedral coordination is furnished by oxido groups and oxygen atoms of methanol or deprotonated methanol molecules. The catalytic properties were investigated for epoxidation of cyclooctene using aqueous tert-butyl hydroperoxide as the oxidant.
- 23 October 2012
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 55 (22) , 9958-9972
Synthesis and Biological Evaluation of 5-Benzylidenepyrimidine-2,4,6(1H,3H,5H)-trione Derivatives for the Treatment of Obesity-Related Nonalcoholic Fatty Liver Disease
Nonalcoholic fatty liver disease (NAFLD), one of chronic liver diseases, seems to be rising as the obesity epidemic continues. In this study, 54 novel (thio)barbituric acid derivatives have been synthesized and evaluated for pharmacological activity. 7h exhibited potent glucose-lowering effects on insulin-resistant HepG2 cells and regulated adiponectin and leptin expression in 3T3-L1 adipocytes. Oral administration of 7h at 25 mg kg–1 day–1 for 4 weeks improved the progression of high fat diet-induced NAFLD by reducing the weight of body, liver, and fat, as well as modulating serum levels of fasting glucose, insulin, triglycerides, LDL-c, ALT, adiponectin and hepatic contents of triglycerides, total cholesterol. H&E stainings revealed that 7h blocked fat deposition in liver and the increase of adipocyte number and size in adipose tissues from NAFLD. Furthermore, treatment with 7h alleviated the obese clinical symptoms, recovered serum biomarkers to appropriate ranges, and improved glucose tolerance by OGTT and IGTT in DIO mice.
- 23 October 2012
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 55 (22) , 9958-9972
Synthesis and Biological Evaluation of 5-Benzylidenepyrimidine-2,4,6(1H,3H,5H)-trione Derivatives for the Treatment of Obesity-Related Nonalcoholic Fatty Liver Disease
Nonalcoholic fatty liver disease (NAFLD), one of chronic liver diseases, seems to be rising as the obesity epidemic continues. In this study, 54 novel (thio)barbituric acid derivatives have been synthesized and evaluated for pharmacological activity. 7h exhibited potent glucose-lowering effects on insulin-resistant HepG2 cells and regulated adiponectin and leptin expression in 3T3-L1 adipocytes. Oral administration of 7h at 25 mg kg–1 day–1 for 4 weeks improved the progression of high fat diet-induced NAFLD by reducing the weight of body, liver, and fat, as well as modulating serum levels of fasting glucose, insulin, triglycerides, LDL-c, ALT, adiponectin and hepatic contents of triglycerides, total cholesterol. H&E stainings revealed that 7h blocked fat deposition in liver and the increase of adipocyte number and size in adipose tissues from NAFLD. Furthermore, treatment with 7h alleviated the obese clinical symptoms, recovered serum biomarkers to appropriate ranges, and improved glucose tolerance by OGTT and IGTT in DIO mice.